LINE

    Text:AAAPrint
    Business

    Pharma companies looking forward to CIIE

    2023-10-26 16:43:56chinadaily.com.cn Editor : Li Yan ECNS App Download

    The booth of Sanofi. (Photo provided to chinadaily.com.cn)

    Multinational pharmaceutical companies said they have high expectations for this year's China International Import Expo, which will be held in Shanghai from Nov 5 to 10, and will bring their latest innovations to support the event.

    United States-based Edwards Lifesciences, for example, will showcase its SAPIEN 3 Ultra RESILIA transcatheter heart valve in China for the first time. Combining the company's breakthrough RESILIA tissue technology with the industry-leading SAPIEN 3 Ultra transcatheter heart valve, this product is currently the only transcatheter heart valve with dry tissue storage in the world.

    Multiple surgical structural heart valve products combing breakthrough RESILIA tissue technology will also be among the key exhibits at the company's booth.

    At the booth of Sanofi, the indication of Dupixent for chronic obstructive pulmonary disease (COPD) will be given its world debut. Dupixent was first exhibited during the inaugural CIIE in 2018.

    Dupixent is the first and only targeted biological agent approved for the treatment of atopic dermatitis, a common immunoinflammatory disease characterized by chronic itching and skin injuries, and covers all age groups.

    The company said that the medicine showed good results in Phase-III clinical research, and was found to improve lung function and quality of life for COPD patients.

    Meanwhile, AstraZeneca will exhibit innovative therapies as well as showcase its substantial investments in promoting local innovation. The company is scheduled to ink collaborations with several local enterprises to jointly develop new drugs, perform research in innovative therapies and help Chinese enterprises go global.

    Taking advantage of AstraZeneca's international experiences, the company has already led Chinese companies to Brazil and the Middle East for exchanges and cooperation so far this year, said Leon Wang, executive vice-president of AstraZeneca.

    "The CIIE is a pioneering initiative by China that benefits the whole world through the development of China's economy," said Wang.

    "It's also an important platform for companies like us to communicate, cooperate and sign contracts with local Chinese governments at different levels, especially those located in major economic belts."

    Related news

    MorePhoto

    Most popular in 24h

    MoreTop news

    MoreVideo

    LINE
    Back to top About Us | Jobs | Contact Us | Privacy Policy
    Copyright ©1999-2023 Chinanews.com. All rights reserved.
    Reproduction in whole or in part without permission is prohibited.
    [網(wǎng)上傳播視聽節(jié)目許可證(0106168)] [京ICP證040655號]
    [京公網(wǎng)安備 11010202009201號] [京ICP備05004340號-1]
    主站蜘蛛池模板: 富民县| 枣阳市| 东乡族自治县| 盱眙县| 门头沟区| 杭锦后旗| 南溪县| 沧源| 永修县| 沁阳市| 鲁甸县| 绿春县| 洱源县| 台江县| 德令哈市| 布尔津县| 建水县| 台前县| 北宁市| 牙克石市| 徐水县| 瑞丽市| 霍州市| 砚山县| 海伦市| 新龙县| 德化县| 沭阳县| 苗栗市| 新建县| 青川县| 玛纳斯县| 淅川县| 靖西县| 高雄县| 额尔古纳市| 婺源县| 凌云县| 民县| 兴山县| 长岛县|